Fitzpatrick Company

Focus: Fitzpatrick Company specializes in solids processing equipment for the biotechnology sector, headquartered in Waterloo, Ontario. The company operates at an undisclosed scale with a focus on oncology and neurology therapeutic areas.

Oncology Neurology

Profile data last refreshed 2d ago · AI intelligence enriched 2w ago

Open Jobs

About Fitzpatrick Company

AI assessmentNot Hiring

No open roles listed right now. Follow Fitzpatrick Company to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Mid-stage

2 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

1064NM pico Laser

Skin Quality

N/A

Clinical Trials (1)

NCT05595525Laser Treatment to Improve Skin Quality

N/A

Help build intelligence for Fitzpatrick Company

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Active pipeline of 30 programs spanning dermatology, aesthetics, and oncology with multiple Phase 2–4 stage programs
Specialized equipment focus positions the company in a niche segment with defensible IP
Located in Waterloo, a major Canadian biotech hub with strong talent infrastructure

Watch Out For

Zero active job openings listed suggests minimal near-term hiring or organizational contraction
Sparse public data on financials, funding, headcount, and stage indicate limited transparency or early-stage opacity
Pipeline heavily weighted toward aesthetic and dermatological indications rather than primary therapeutic focus (oncology, neurology)

Generated by Claude from Fitzpatrick Company's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

AGE Serum

Laxity; Skin

N/A

Clinical Trials (2)

NCT07558603Evaluate the Safety and Efficacy of AGE Serum in Post-menopausal Patients on Hormone Replacement Therapy Taking Glucagon-like Peptide-1 Agonist

N/A

NCT07216352Evaluate the Safety and Efficacy of a Topical Serum (AGE Serum) in Improving Visible Signs of Aging

N/A

Nonablative fractional laser

Atrophic Acne Scar

N/A

Clinical Trials (1)

NCT05105334Combined Therapy for Acne Scars

N/A

Picosecond 755nm Alexandrite Laser

Acne Scars

N/A

Clinical Trials (1)

NCT05579171Lasers to Aid in Treatment of Acne Scars

N/A

CeraVe

Face Rejuvenation

N/A

Clinical Trials (1)

NCT05808842Laser Treatment for Facial and Neck Rejuvenation

N/A

A Clinical Study Evaluaing the Efficacy, Safety, and Patient Satisfaction of Injectable Hylaronic Ac

Wrinkles

N/A

Clinical Trials (1)

NCT01267149A Clinical Study Evaluaing the Efficacy, Safety, and Patient Satisfaction of Injectable Hylaronic Acid With 0.3% Lidocain Hydrochloride, Prevelle Silk, for Superficial, Vertical Perioral Lines and Superficial, Horizontal, Lateral Canthal Lines

N/A

TR987 Gel with Silon Bandage

Exposure Laser

N/A

Clinical Trials (1)

NCT02681224TR-987 vs. Placebo Following Fractionated CO2 Laser Resurfacing of the Chest

N/A

Picoway

Striae; Albicantes

N/A

Clinical Trials (1)

NCT03750422Stretch Marks on Abdomen

N/A

CoolSculpting Elite combined with CoolTone Treatments

Improved Appearance of the Banana Roll Region

N/A

Clinical Trials (1)

NCT05359614Coolsculpting With Cooltone Verses Coolsculpting Alone for the Banana Roll Area

N/A

1550nm non-ablative fractional laser

Female Pattern Baldness

N/A

Clinical Trials (1)

NCT069260231550nm Non-ablative Fractional Vs 1927nm Thulium Fractional Laser for the Treatment of Female Pattern Hair Loss

N/A

Restylane® Silk

Wrinkle

N/A

Clinical Trials (1)

NCT03461198Micro-injections of Transparent Hyaluronic Acid Gel (Restylane® Silk) for Rejuvenation of the Aging Cheek

N/A

Hyaluronic Acid filler

Problem of Aging

N/A

M22 IPL

Keratosis Pilaris

N/A

Clinical Trials (1)

NCT05666011Laser to Aid in Treatment of Keratosis Pilaris on Arms

N/A

DOSE formulation

Melasma

N/A

Clinical Trials (1)

NCT04137263Study Evaluating the Efficacy of DOSE Formulations in Treating Melasma and Cutaneous Signs of Aging

N/A

Sculptra Aesthetic

Cellulite

N/A

Restylane® Silk

Wrinkle

N/A

Clinical Trials (1)

NCT03742479Restylane Silk Microinjections to Cheeks

N/A

Secret RF

Aging

N/A

Clinical Trials (1)

NCT03426098Secret Micro-Needle Fractional RF System® for the Treatment of Facial Wrinkles

N/A

injectable poly-L-lactic acid

Skin Laxity

N/A

Calcium Hydroxylapatite and Triamcinolone acetate

Volume Loss to Dorsum of Hands

N/A

Clinical Trials (1)

NCT02454088A Single-Center Investigator-Initiated Evaluator-Bilateral-Comparison Pilot Study of Injectable Calcium Hydroxylapatite With and Without Triamcinolone Acetate for the Treatment of Volume Loss to Dorsum Areas of the Hands

N/A

injectable poly-L-lactic acid

Skin Laxity

N/A

poly-L-lactic acid to right knee

Lax Skin

N/A

Antihistamine Cetirizine Hydrochloride

Actinic Keratoses

N/A

Clinical Trials (1)

NCT02451579A Clinical Trial Evaluating the Role of Systemic Antihistamine Therapy in the Reduction of Adverse Effects Associated With Topical 5-aminolevulinic Acid Photodynamic Therapy

N/A

Sofwave

Skin Laxity

N/A

Clinical Trials (1)

NCT05355714High Intensity Ultrasound for the Treatment of Upper Inner Arm Skin Laxity

N/A

Pavise Serum

Skin Laxity

Phase 2

Clinical Trials (1)

NCT07462533Assess Efficacy of a Nanodiamond Periprocedural Skin Care Regimen for Ablative Resurfacing

Phase 2

Sculptra Aesthetic

Laxity; Skin

Phase 2

Clinical Trials (1)

NCT07217743Assess Impact of Poly-L-lactic Acid on GLP1 Subjects

Phase 2

Sodium Tetradecyl Sulfate

Epidermoid Cyst

Phase 2

Clinical Trials (1)

NCT05597995Treatment of Epidermoid Cysts

Phase 2

Skinvive

Wrinkle

Phase 2

Clinical Trials (1)

NCT07221461Assess Impact of Microdroplet Hyaluronic Acid Filler on Skin Quality in Patients on Glucagon-like Peptide-1 Agonists

Phase 2

Babor Ultimate ECM Repair Serum

Facial Wrinkles

Phase 2/3

Clinical Trials (1)

NCT06638905Efficacy and Safety of Skincare Serum and Cream for Anti-aging of Facial Skin

Phase 2/3

CE Ferulic

Improve Photoaging Signs

Phase 2/3

Clinical Trials (1)

NCT06603857Skin Care Regimen for Improving Photoaging Signs on the Face

Phase 2/3

Barrier Renew

Redness

Phase 3

Clinical Trials (1)

NCT05961579Evaluating the Efficacy and Safety of Cleanser, Serum, and Sunscreen Products for Facial Redness.

Phase 3

enhanced DefenAge 8-in-1 BioSerum

Periorbital Wrinkles

Phase 3

Injectable sodium deoxycholate

Adiposity

Phase 4

tretinoin 0.05% lotion

Photodamaged Skin

Phase 4

air cooling

Leg Veins

Phase 4

Clinical Trials (1)

NCT04690803The Effect of Cooling on Sclerotherapy Efficacy

Phase 4

aminolevulinic acid hydrochloride gel, 10%

Skin Neoplasms

Phase 4

Right leg treated with Glycerin compounded with 1% Lidocaine and Epinephrine

Leg Veins

Phase 4

Clinical Trials (1)

NCT07342413Study Comparing Glycerin With 1% Lidocaine and Epinephrine Versus Glycerin With 1% Lidocaine Without Epinephrine for the Sclerotherapy of Leg Telangiectasias

Phase 4

Sodium Deoxycholate

Fat Reduction

Phase 4

Obagi® Saypha® MagIQ™ Injectable Hyaluronic Acid

Fine Lines

Phase 4

Clinical Trials (1)

NCT07421544Assess Injectable Hyaluronic Acid Gel for the Treatment of Volume Loss, Skin Laxity and Fine Lines

Phase 4

Inggenol Mebutate 0.015%

Actinic Keratosis